Catalyst Wire Dossier Catalyst Wire Dossier

YR011

· Hangzhou Yirui Pharmaceutical Technology Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YR011, covering 2025-12-26 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet [Phase 1]

See pricing